Abstract
The analysis of electrophysiological signals from the human body has become increasingly crucial, especially given the widespread adoption of wearable technologies and the growing trend of remote and online monitoring. In situations where demographic patient data is unavailable, the evaluation of such information from electrophysiological signals becomes imperative for making well-informed diagnostic and therapeutic decisions, particularly in ambulatory and urgent cases. This study underscores the significance of this necessity by utilizing intracardiac electrograms to predict patient weight.
Intracardiac electrograms were recorded from 44 patients (14 female, with an average age of 59.2±11.5 years) using a 64-pole basket catheter over a duration of 60 seconds. A dataset comprising 2,816 unipolar electrogram signal segments, each lasting 4 seconds, was utilized. Weight, considered as a continuous variable, underwent discretization into k bins with uniformly distributed widths, where various values of k were experimented with. As the value of k increases, class imbalance also increases.
The state-of-the-art time series classification algorithm, Minirocket, was employed alongside the popular machine learning algorithm eXtreme Gradient Boosting (XGBoost). Minirocket consistently demonstrates superior performance compared to XGBoost across all class number scenarios and across all evaluation metrics, such as accuracy, F1 score, and Area Under the Curve (AUC) values, achieving scores of approximately 0.96. Conversely, XGBoost shows signs of overfitting, particularly noticeable in scenarios with higher class imbalance. Tuning probability thresholds for classes could potentially mitigate this issue. Additionally, XGBoost’s performance improves with reduced bin numbers, emphasizing the importance of balanced classes. This study provides novel insights into the predictive capabilities of these algorithms and their implications for personalized medicine and remote health monitoring.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
https://clinicaltrials.gov/study/NCT02997254?cond=NCT02997254&rank=1
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of National Library of Medicine gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
